Cancer cells remain elusive and tough to locate, but a new crop of nuclear-imaging tests promises to lead to more accurate prognosis and treatment. The tests use imaging agents that combine radioactive isotopes with targeted molecules that can spot cancer at the cellular level.
Rati-Fi® Informed Consent
Rati-Fi® Informed Consent
